Research Article
Different Patterns of Bacterial Species and Antibiotic Susceptibility in Diabetic Foot Syndrome with and without Coexistent Ischemia
Table 5
Susceptibility of bacterial strains to antibiotics in the entire study group, in people with or without PAD (peripheral arterial disease).
| | Antibacterial agent | Susceptibility in all patients | Susceptibility in patients with PAD | Susceptibility in patients without PAD | Statistical significance, |
| | Penicillins and penicillins with beta-lactamase inhibitor | | Penicillin G | 23% | 20% | 28% | | | Ampicillin | 27% | 26% | 30% | | | Amoxicillin | 26% | 25% | 30% | | | Amoxicillin with clavulanate | 53% | 51% | 61% | | | Piperacillin with tazobactam | 57% | 57% | 59% | | | Cephalosporins | | Cephalexin | 26% | 24% | 31% | | | Cephadroxyl | | Cefazolin | | Cefaclor | | Cefuroxime | 35% | 33% | 39% | | | Ceftazidime | 30% | 33% | 24% | | | Cefotaxime | 48% | 47% | 50% | | | Ceftriaxone | 49% | 47% | 51% | | | Cefixime | 31% | 32% | 27% | | | Ceftybuten | 30% | 32% | 27% | | | Cefepime | 62% | 62% | 64% | | | Ceftalozane | 37% | 39% | 32% | | | Ceftaroline | 58% | 56% | 64% | | | Monobactams | | Aztreonam | 29% | 31% | 22% | | | Carbapenems | | Meropenem | 82% | 83% | 80% | | | Imipenem with cilastatin | 79% | 80% | 76% | | | Ertapenem | 79% | 79% | 81% | | | Glycopeptides | | Vancomycin | 50% | 46% | 58% | | | Teicoplanin | 50% | 46% | 59% | | | Dalbavancin | 50% | 47% | 59% | | | Lipopeptides | | Daptomycin | 48% | 45% | 57% | | | Aminoglycosides | | Gentamicin | 65% | 67% | 63% | | | Amikacin | 65% | 66% | 65% | | | Tobramycin | 68% | 68% | 69% | | | Tetracyclines | | Doxycycline | 40% | 38% | 44% | | | Glycylcycline | | Tigecycline | 75% | 53% | 80% | | | Macrolides | | Erythromycin | 9% | 9% | 11% | | | Clarithromycin | 9% | 8% | 10% | | | Azithromycin | | Lincosamides | | Clindamycin | 24% | 22% | 28% | | | Oxazolidinones | | Linezolid | 47% | 43% | 56% | | | Fluoroquinolones | | Ciprofloxacin | 35% | 36% | 29% | | | Levofloxacin | 37% | 39% | 29% | | | Moxifloxacin | 31% | 34% | 24% | | | Sulfonamides | | Cotrimoxazole | 45% | 45% | 46% | | | Nitroimidazoles | | Metronidazole | 4% | 5% | 2% | | | Polymyxins | | Colistin | 34% | 38% | 26% | |
|
|
